Literature DB >> 11772539

Endogenous and exogenous interferons in HIV-infection.

A V Karpov1.   

Abstract

The interferons (IFNs) belong to the body's natural defensive response mechanisms directed against virus infections including also the human immunodeficiency virus (HIV) infection. This review discusses the current knowledge concerning the role of IFNs types I and II during the HIV infection. The author analyzes the HIV-driven process of endogenous IFNs induction in different cell types as well as the development of unusual acid-labile IFN following the HIV infection, its nature and clinical significance. Possible action mechanisms of different exogenous IFN types against the HIV-infection are reviewed taking into consideration the stages of HIV replication accompanied by these mechanisms of action and describing both positive and negative roles of IFNs during this disease. The author discusses also some well-known IFN-inducible antiviral pathways participating in the anti-HIV mechanisms and enzymes realizing antiviral action (PKR, 2'5'-OAS, iNOS, IDO, Mx and 9-27 proteins). A problem of HIV defense against the anti-HIV IFN action as well as some aspects of HIV-accelerating IFN effects are also examined in detail.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11772539

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  10 in total

Review 1.  Barriers to mucosal transmission of immunodeficiency viruses.

Authors:  Brandon F Keele; Jacob D Estes
Journal:  Blood       Date:  2011-05-09       Impact factor: 22.113

2.  Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect.

Authors:  Samantha Brandler; Alice Lepelley; Marion Desdouits; Florence Guivel-Benhassine; Pierre-Emmanuel Ceccaldi; Yves Lévy; Olivier Schwartz; Arnaud Moris
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 3.  Plasmacytoid dendritic cells in HIV infection.

Authors:  Meagan O'Brien; Olivier Manches; Nina Bhardwaj
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

4.  CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.

Authors:  Erika Schlaepfer; Annette Audigé; Barbara von Beust; Vania Manolova; Markus Weber; Helene Joller; Martin F Bachmann; Thomas M Kundig; Roberto F Speck
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Modulation of type I interferon-associated viral sensing during acute simian immunodeficiency virus infection in African green monkeys.

Authors:  Simon P Jochems; Gaël Petitjean; Désirée Kunkel; Anne-Sophie Liovat; Mickaël J Ploquin; Françoise Barré-Sinoussi; Pierre Lebon; Béatrice Jacquelin; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

6.  Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.

Authors:  Daniela Vendrame; Marion Sourisseau; Virginie Perrin; Olivier Schwartz; Fabrizio Mammano
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

7.  Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.

Authors:  Núria Climent; Susana Guerra; Felipe García; Cristina Rovira; Laia Miralles; Carmen Elena Gómez; Núria Piqué; Cristina Gil; José María Gatell; Mariano Esteban; Teresa Gallart
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

8.  Effect of type-I interferon on retroviruses.

Authors:  Esperanza Gómez-Lucía; Victorio M Collado; Guadalupe Miró; Ana Doménech
Journal:  Viruses       Date:  2009-10-27       Impact factor: 5.048

9.  The interferon response inhibits HIV particle production by induction of TRIM22.

Authors:  Stephen D Barr; James R Smiley; Frederic D Bushman
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

Review 10.  Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design.

Authors:  Danushka Kumara Wijesundara; Yang Xi; Charani Ranasinghe
Journal:  Front Immunol       Date:  2014-08-29       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.